[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 43, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 941316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 79, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 918124, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 38, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 689959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 42, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 53, "title": "Chief People Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 59, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.34, "open": 5.29, "dayLow": 5.06, "dayHigh": 5.55, "regularMarketPreviousClose": 5.34, "regularMarketOpen": 5.29, "regularMarketDayLow": 5.06, "regularMarketDayHigh": 5.55, "payoutRatio": 0.0, "beta": 0.472, "forwardPE": -3.6670384, "volume": 1893449, "regularMarketVolume": 1893449, "averageVolume": 1824975, "averageVolume10days": 4116480, "averageDailyVolume10Day": 4116480, "bid": 5.34, "ask": 5.41, "bidSize": 10, "askSize": 7, "marketCap": 346095040, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 10.08, "allTimeHigh": 33.99, "allTimeLow": 1.0, "fiftyDayAverage": 6.246, "twoHundredDayAverage": 4.58985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 122448272, "profitMargins": 0.0, "floatShares": 49319832, "sharesOutstanding": 64569967, "sharesShort": 10924303, "sharesShortPriorMonth": 7289153, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.1692, "heldPercentInsiders": 0.17849001, "heldPercentInstitutions": 0.4609, "shortRatio": 8.45, "shortPercentOfFloat": 0.19489999, "impliedSharesOutstanding": 64569967, "bookValue": 3.591, "priceToBook": 1.4926205, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -62496372, "trailingEps": -1.79, "forwardEps": -1.46167, "enterpriseToEbitda": -1.919, "52WeekChange": 1.8105264, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 5.36, "targetHighPrice": 30.0, "targetLowPrice": 11.0, "targetMeanPrice": 16.83333, "targetMedianPrice": 14.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 227563072, "totalCashPerShare": 3.524, "ebitda": -63817392, "totalDebt": 3916329, "quickRatio": 23.84, "currentRatio": 24.002, "debtToEquity": 1.718, "returnOnAssets": -0.25912002, "returnOnEquity": -0.4375, "freeCashflow": -27747748, "operatingCashflow": -50014512, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "regularMarketChangePercent": 0.374531, "regularMarketPrice": 5.36, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 0.18656254, "postMarketPrice": 5.37, "postMarketChange": 0.009999752, "regularMarketChange": 0.02, "regularMarketDayRange": "5.06 - 5.55", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1824975, "fiftyTwoWeekLowChange": 4.26, "fiftyTwoWeekLowChangePercent": 3.8727274, "fiftyTwoWeekRange": "1.1 - 10.08", "fiftyTwoWeekHighChange": -4.72, "fiftyTwoWeekHighChangePercent": -0.46825394, "corporateActions": [], "postMarketTime": 1769216313, "regularMarketTime": 1769202001, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekChangePercent": 181.05264, "earningsTimestamp": 1762981200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "earningsCallTimestampStart": 1762808400, "earningsCallTimestampEnd": 1762808400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.79, "epsForward": -1.46167, "epsCurrentYear": -1.41667, "priceEpsCurrentYear": -3.7835207, "fiftyDayAverageChange": -0.8859997, "fiftyDayAverageChangePercent": -0.14185074, "twoHundredDayAverageChange": 0.7701502, "twoHundredDayAverageChangePercent": 0.1677942, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]